NFKB1 and COVID-19: In a second study upregulation of TLR4, IL1R, NF-κB signaling pathway molecules in COVID-19 patients were found, associated with the altered immune responses to viral components, host damage-associated molecular pattern (DAMP) signals, and cytokine signaling activation, resembling those seen with bacterial sepsis.